
Although requests for measles vaccinations are increasing, pharmacists may be limited by state laws.

Although requests for measles vaccinations are increasing, pharmacists may be limited by state laws.

Safety monitoring findings for Shingrix are consistent with clinical trial data.

Pregnancy and menopause are contributing factors.

CDC reports seasonal influenza activity remains elevated and widespread throughout U.S.

Be aware of the contraindications for Shingrix and Zostavax


Rounding up the news you need to know to start the new year.

Shingrix is in short supply due to high demand, so the maker is upping the supply.

Misconceptions about the risks and benefits of the seasonal flu vaccine are at a three-year high.

What patients can expect after Shingrix or Zostavax injections.

Here’s how to protect the population that’s at highest risk for shingles complications.

New study reveals that immunization registries, communication, and the completion of immunization series can increase pharmacists' role in the immunization process.

Research in mice has found that a vaccine may be able to help prevent the recurrence of strokes.

A study of vaccination exemptions in kids found that some doctors are charging anti-vaccine parents for them.

The FDA has approved the first new treatment for flu in decades. Here's how it will impact sales of Tamiflu and vaccination rates.

Shingles has a lot of numbers to consider, starting with one million cases a year in the United States.

States hope to improve vaccination rates in low-income families using state registries.

Combination live attenuated and DNA vaccine development could simplify vaccine production, lowering costs.

Flu vaccinations can take up lots of your already-busy schedule, but that doesn’t mean they’re not important.

Pharmacists are in an ideal position to encourage people to be vaccinated against shingles.

After a bad 2017 season, pharmacies and the FDA are pushing the public to still get flu vaccines.

A retroactive study finds no connection between HPV and other vaccines and primary ovarian insufficiency.

There could be significant gains in adult vaccination rates if Insurers were required to cover vaccinations in pharmacies

